MX2007007262A - Metabolitos de analogos de ciclosporina. - Google Patents

Metabolitos de analogos de ciclosporina.

Info

Publication number
MX2007007262A
MX2007007262A MX2007007262A MX2007007262A MX2007007262A MX 2007007262 A MX2007007262 A MX 2007007262A MX 2007007262 A MX2007007262 A MX 2007007262A MX 2007007262 A MX2007007262 A MX 2007007262A MX 2007007262 A MX2007007262 A MX 2007007262A
Authority
MX
Mexico
Prior art keywords
metabolites
isa247
methods
formation
synthetic methods
Prior art date
Application number
MX2007007262A
Other languages
English (en)
Inventor
Randall W Yatscoff
Robert T Foster
Seetharaman Jayaraman
Mark D Abel
Derrick G Freitag
Daniel J Trepanier
Shin Sugiyama
Original Assignee
Isotechnika Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isotechnika Inc filed Critical Isotechnika Inc
Publication of MX2007007262A publication Critical patent/MX2007007262A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Abstract

Se describen los metabolitos aislados del analogo de ciclosporina ISA247, incluyendo los metodos in vitro para su preparacion. Los metabolitos comprenden una modificacion quimica de ISA247, en donde la modificacion es al menos una reaccion seleccionada del grupo que consiste de hidroxilacion, N-desmetilacion, formacion de diol, formacion de epoxido, y fosforilacion por ciclizacion intramolecular, sulfatacion, formacion de glucuronido y glucosilacion. Los metodos de preparacion incluyen los metodos semi-sinteticos, en donde los metabolitos de ISA247 son producidos a traves de los extractos microsomales de celulas hepaticas de animal, o de cultivos utilizando microorganismos, y metodos completamente sinteticos, tales como la modificacion quimica del compuesto progenitor o los metabolismos aislados utilizando metodos sinteticos organicos.
MX2007007262A 2004-12-17 2005-12-19 Metabolitos de analogos de ciclosporina. MX2007007262A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63739204P 2004-12-17 2004-12-17
PCT/CA2005/001926 WO2006063470A1 (en) 2004-12-17 2005-12-19 Metabolites of cyclosporin analogs

Publications (1)

Publication Number Publication Date
MX2007007262A true MX2007007262A (es) 2007-10-19

Family

ID=36587506

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007262A MX2007007262A (es) 2004-12-17 2005-12-19 Metabolitos de analogos de ciclosporina.

Country Status (14)

Country Link
US (1) US20060223743A1 (es)
EP (1) EP1828229A4 (es)
JP (1) JP2008524122A (es)
KR (1) KR20070100284A (es)
CN (1) CN101120012A (es)
AU (1) AU2005316095A1 (es)
BR (1) BRPI0517207A (es)
CA (1) CA2592343A1 (es)
IL (1) IL183908A0 (es)
MX (1) MX2007007262A (es)
TN (1) TNSN07225A1 (es)
TW (1) TW200635954A (es)
WO (1) WO2006063470A1 (es)
ZA (1) ZA200705475B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
AU2007271088A1 (en) * 2006-07-06 2008-01-10 Ares Trading S.A. An oral pharmaceutical composition of an anilinopyrimidine, its preparation and use thereof
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
EP2151450A1 (de) * 2008-07-29 2010-02-10 Sandoz AG Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden
US20130190223A1 (en) * 2008-07-30 2013-07-25 Isotechnika Pharma Inc. Nonimmunosuppressive cyclosporine analogue molecules
RU2012126681A (ru) * 2009-06-02 2014-01-10 НИКАН ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Антагонизм рецептора формил-пептида человека для лечения заболеваний
MX353720B (es) * 2010-12-15 2018-01-25 Contravir Pharmaceuticals Inc Moleculas analogas de ciclosporina modificadas en el aminoacido 1 y 3.
AR090964A1 (es) * 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos
AR111963A1 (es) * 2017-05-26 2019-09-04 Univ California Método y moléculas
WO2019196953A1 (en) * 2018-04-13 2019-10-17 National Institute Of Biological Sciences, Beijing Ntcp inhibitors
CN110174363A (zh) * 2019-01-09 2019-08-27 北京九强生物技术股份有限公司 6-磷酸葡萄糖脱氢酶突变体及其在制备检测试剂中的用途
CN113388002A (zh) * 2021-06-10 2021-09-14 梯尔希（南京）药物研发有限公司 一种环孢菌素相关化合物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE95193T1 (de) * 1987-06-17 1993-10-15 Sandoz Ag Cyclosporine und deren benutzung als arzneimittel.
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
US5834266A (en) * 1993-02-12 1998-11-10 President & Fellows Of Harvard College Regulated apoptosis
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
ATE423130T1 (de) * 1997-10-08 2009-03-15 Isotechnika Inc Deuterierte cyclosporin-analoga und ihre verwendung als immunmodulierende agenzien
US6784156B2 (en) * 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
DK1714977T3 (da) * 2001-10-19 2009-07-06 Isotechnika Inc Syntese af cyclosporinanaloger
PL210697B1 (pl) * 2001-10-19 2012-02-29 Isotechnika Inc Kompozycja zawierająca mieszaninę izomerów analogu cyklosporyny i zastosowanie tej mieszaniny
US20040110666A1 (en) * 2002-12-04 2004-06-10 Or Yat Sun Cyclosporins for the treatment of immune disorders
US7012065B2 (en) * 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
CA2518265A1 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US20040266669A1 (en) * 2003-06-20 2004-12-30 Wu Frank X. H. Cyclosporin derivatives for the treatment of immune disorders

Also Published As

Publication number Publication date
WO2006063470B1 (en) 2006-08-03
BRPI0517207A (pt) 2008-09-30
CA2592343A1 (en) 2006-06-22
IL183908A0 (en) 2007-10-31
WO2006063470A1 (en) 2006-06-22
TW200635954A (en) 2006-10-16
CN101120012A (zh) 2008-02-06
JP2008524122A (ja) 2008-07-10
AU2005316095A1 (en) 2006-06-22
US20060223743A1 (en) 2006-10-05
EP1828229A1 (en) 2007-09-05
ZA200705475B (en) 2008-07-30
EP1828229A4 (en) 2010-06-30
KR20070100284A (ko) 2007-10-10
TNSN07225A1 (en) 2008-11-21

Similar Documents

Publication Publication Date Title
MX2007007262A (es) Metabolitos de analogos de ciclosporina.
Jensen et al. The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery
König et al. Natural products from marine organisms and their associated microbes
Cragg et al. Impact of natural products on developing new anti-cancer agents
Skropeta et al. Recent advances in deep-sea natural products
Bugni et al. Marine-derived fungi: a chemically and biologically diverse group of microorganisms
Rateb et al. Secondary metabolites of fungi from marine habitats
Finefield et al. Fungal origins of the bicyclo [2.2. 2] diazaoctane ring system of prenylated indole alkaloids
Salomon et al. Merging the potential of microbial genetics with biological and chemical diversity: an even brighter future for marine natural product drug discovery
WO2006040763A8 (en) Isolated primate embryonic cells and methods of generating and using same
Kita et al. Symbiodinolide, a novel polyol macrolide that activates N-type Ca2+ channel, from the symbiotic marine dinoflagellate Symbiodinium sp.
Raja et al. Phylogenetic and chemical diversity of fungal endophytes isolated from Silybum marianum (L) Gaertn.(milk thistle)
Amna et al. Effect of precursors feeding and media manipulation on production of novel anticancer pro-drug camptothecin from endophytic fungus
Uka et al. Secondary metabolite dereplication and phylogenetic analysis identify various emerging mycotoxins and reveal the high intra-species diversity in Aspergillus flavus
Mishra et al. Exploiting endophytic microbes as micro-factories for plant secondary metabolite production
Devine et al. Future directions for the discovery of antibiotics from actinomycete bacteria
KR20050086873A (ko) 매크로라이드계 화합물의 제조 방법
Ebel 20 natural products from marine derived fungi
Liu et al. Xyloketal H from the mangrove endophytic fungus Xylaria sp. 2508
Wang et al. Discovery of cymopolyphenols A–F from a marine mesophotic zone Aaptos sponge-associated fungus Cymostachys sp. NBUF082
WO2007031556A3 (en) Means and methods to enhance the production of vinblastine and vincristine in catharanthus roseus
Orjala et al. Discovery of potential anticancer agents from aquatic cyanobacteria, filamentous fungi, and tropical plants
Zotchev Alkaloids from marine bacteria
Giddings et al. Bioactive compounds from extremophilic marine fungi
Kutney Plant cell cultures and synthetic chemistry-a potentially powerful route to complex natural products

Legal Events

Date Code Title Description
FA Abandonment or withdrawal